ACIP Vaccine Policy Concerns

By João L. Carapinha

June 19, 2025

The JAMA article “Advisory Committee on Immunization Practices at a Crossroads” highlights significant ACIP vaccine policy concerns following the abrupt dismissal of all ACIP members in June 2025. Their replacement with new appointees threatens th...
Efficacy of Ultomiris Pediatric TMA Treatment
PCV20 Reimbursement Guidelines: Analysis of Dutch Advisory Council Recommenda...
KEYTRUDA Head Neck Cancer Approval: Transforming Treatment and Health Economics
Mavyret Acute Hepatitis C: Pioneering Treatment Expansion and Economic Implic...
Advancements in HIV Vaccine Trials: Promising Results from mRNA Strategies
Telemedicine Growth Strategies: Insights from the WHO European Region
RFK Jr.’s ACIP Overhaul: Examining Vaccine Policy Implications
The Case for Transparency in Peer Review: Enhancing Scientific Integrity and ...
Quantifying EU Medicine Access Challenges
Enhertu Reimbursement Analysis: Navigating Cost-Effectiveness Challenges
BioNTech BMS Collaboration: Pioneering Advances in Solid Tumor Treatment with...
Pluvicto Prostate Cancer Trial: Phase III Results